Search

Your search keyword '"Turner, Paul J."' showing total 673 results

Search Constraints

Start Over You searched for: Author "Turner, Paul J." Remove constraint Author: "Turner, Paul J."
673 results on '"Turner, Paul J."'

Search Results

2. Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent

3. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

5. Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

7. Global disparities in availability of epinephrine auto-injectors

8. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

10. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

13. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

16. Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

17. Managing food allergy: GA2LEN guideline 2022

20. Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis

21. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

22. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.

24. Contributors

28. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

29. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

31. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review

33. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

35. Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review

37. World Allergy Organization Anaphylaxis Guidance 2020

38. Improving "may contain" labels: A call to team up and share data.

41. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

43. Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens

48. Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

49. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

Catalog

Books, media, physical & digital resources